000 | 01393 a2200433 4500 | ||
---|---|---|---|
005 | 20250512114156.0 | ||
264 | 0 | _c19730912 | |
008 | 197309s 0 0 eng d | ||
022 | _a0037-1963 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSmith, R P | |
245 | 0 | 0 |
_aDrug-induced methemoglobinemia. _h[electronic resource] |
260 |
_bSeminars in hematology _cJul 1973 |
||
300 |
_a253-68 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAnalgesics _xadverse effects |
650 | 0 | 4 |
_aAnesthetics, Local _xadverse effects |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnti-Infective Agents _xadverse effects |
650 | 0 | 4 |
_aAnticoagulants _xadverse effects |
650 | 0 | 4 | _aCats |
650 | 0 | 4 | _aDogs |
650 | 0 | 4 | _aExchange Transfusion, Whole Blood |
650 | 0 | 4 |
_aGlutethimide _xadverse effects |
650 | 0 | 4 | _aGuinea Pigs |
650 | 0 | 4 |
_aHemoglobinopathies _xgenetics |
650 | 0 | 4 |
_aHemoglobins _xmetabolism |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHydroxylamines _xtherapeutic use |
650 | 0 | 4 | _aHyperbaric Oxygenation |
650 | 0 | 4 |
_aMethemoglobinemia _xchemically induced |
650 | 0 | 4 |
_aMethylene Blue _xtherapeutic use |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aOxidation-Reduction |
650 | 0 | 4 |
_aPhenytoin _xadverse effects |
650 | 0 | 4 |
_aVasodilator Agents _xadverse effects |
700 | 1 | _aOlson, M V | |
773 | 0 |
_tSeminars in hematology _gvol. 10 _gno. 3 _gp. 253-68 |
|
999 |
_c4581736 _d4581736 |